Beam Therapeutics (BEAM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...
Editas Medicine (EDIT) will present updated safety and efficacy data in 28 patients living with severe sickle cell disease treated with ...
New data shed light on the risks for complications when female patients with sickle cell disease undergo fertility ...